Celebrity Fashions Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 22, 2025, 8:11 am

Competitors of Celebrity Fashions Ltd

All Competitor Stocks of Celebrity Fashions Ltd

Quarterly Result

Last Updated: August 20, 2025, 12:25 pm

Below is a detailed analysis of the quarterly data for Celebrity Fashions Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 40.67 Cr.. The value appears to be declining and may need further review. It has decreased from 51.51 Cr. (Mar 2025) to 40.67 Cr., marking a decrease of 10.84 Cr..
• For Expenses, as of Jun 2025, the value is 44.86 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 50.47 Cr. (Mar 2025) to 44.86 Cr., marking a decrease of 5.61 Cr..
• For Operating Profit, as of Jun 2025, the value is -4.19 Cr.. The value appears to be declining and may need further review. It has decreased from 1.04 Cr. (Mar 2025) to -4.19 Cr., marking a decrease of 5.23 Cr..
• For OPM %, as of Jun 2025, the value is -10.30%. The value appears to be declining and may need further review. It has decreased from 2.02% (Mar 2025) to -10.30%, marking a decrease of 12.32%.
• For Other Income, as of Jun 2025, the value is 0.03 Cr.. The value appears to be declining and may need further review. It has decreased from 0.34 Cr. (Mar 2025) to 0.03 Cr., marking a decrease of 0.31 Cr..
• For Interest, as of Jun 2025, the value is 1.41 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.01 Cr. (Mar 2025) to 1.41 Cr., marking a decrease of 0.60 Cr..
• For Depreciation, as of Jun 2025, the value is 1.16 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.52 Cr. (Mar 2025) to 1.16 Cr., marking a decrease of 0.36 Cr..
• For Profit before tax, as of Jun 2025, the value is -6.73 Cr.. The value appears to be declining and may need further review. It has decreased from -2.15 Cr. (Mar 2025) to -6.73 Cr., marking a decrease of 4.58 Cr..
• For Tax %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
• For Net Profit, as of Jun 2025, the value is -6.73 Cr.. The value appears to be declining and may need further review. It has decreased from -2.15 Cr. (Mar 2025) to -6.73 Cr., marking a decrease of 4.58 Cr..
• For EPS in Rs, as of Jun 2025, the value is -1.13. The value appears to be declining and may need further review. It has decreased from -0.36 (Mar 2025) to -1.13, marking a decrease of 0.77.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 5:35 am

Growth

Last Updated: September 5, 2025, 1:40 am

Balance Sheet

Last Updated: June 16, 2025, 12:19 pm

Below is a detailed analysis of the balance sheet data for Celebrity Fashions Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 60.00 Cr.. The value appears strong and on an upward trend. It has increased from 57.00 Cr. (Mar 2024) to 60.00 Cr., marking an increase of 3.00 Cr..
• For Reserves, as of Mar 2025, the value is -39.00 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from -23.00 Cr. (Mar 2024) to -39.00 Cr., marking a decline of 16.00 Cr..
• For Borrowings, as of Mar 2025, the value is 68.00 Cr.. The value appears to be increasing, which may not be favorable. However, Reserves are negative, which is a major warning sign. It has increased from 67.00 Cr. (Mar 2024) to 68.00 Cr., marking an increase of 1.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 59.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 42.00 Cr. (Mar 2024) to 59.00 Cr., marking an increase of 17.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 147.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 143.00 Cr. (Mar 2024) to 147.00 Cr., marking an increase of 4.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 25.00 Cr.. The value appears to be declining and may need further review. It has decreased from 31.00 Cr. (Mar 2024) to 25.00 Cr., marking a decrease of 6.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 122.00 Cr.. The value appears strong and on an upward trend. It has increased from 112.00 Cr. (Mar 2024) to 122.00 Cr., marking an increase of 10.00 Cr..
• For Total Assets, as of Mar 2025, the value is 147.00 Cr.. The value appears strong and on an upward trend. It has increased from 143.00 Cr. (Mar 2024) to 147.00 Cr., marking an increase of 4.00 Cr..

However, the Borrowings (68.00 Cr.) are higher than the Reserves (-39.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Celebrity Fashions Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -3.26. This value is below the healthy minimum of 5. It has decreased from 0.40 (Mar 24) to -3.26, marking a decrease of 3.66.
• For Diluted EPS (Rs.), as of Mar 25, the value is -3.26. This value is below the healthy minimum of 5. It has decreased from 0.40 (Mar 24) to -3.26, marking a decrease of 3.66.
• For Cash EPS (Rs.), as of Mar 25, the value is -2.01. This value is below the healthy minimum of 3. It has decreased from 1.76 (Mar 24) to -2.01, marking a decrease of 3.77.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 3.44. It has decreased from 6.01 (Mar 24) to 3.44, marking a decrease of 2.57.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 3.44. It has decreased from 6.01 (Mar 24) to 3.44, marking a decrease of 2.57.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 27.69. It has decreased from 60.59 (Mar 24) to 27.69, marking a decrease of 32.90.
• For PBDIT / Share (Rs.), as of Mar 25, the value is -1.04. This value is below the healthy minimum of 2. It has decreased from 3.46 (Mar 24) to -1.04, marking a decrease of 4.50.
• For PBIT / Share (Rs.), as of Mar 25, the value is -2.09. This value is below the healthy minimum of 0. It has decreased from 2.03 (Mar 24) to -2.09, marking a decrease of 4.12.
• For PBT / Share (Rs.), as of Mar 25, the value is -3.06. This value is below the healthy minimum of 0. It has decreased from 0.32 (Mar 24) to -3.06, marking a decrease of 3.38.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -3.06. This value is below the healthy minimum of 2. It has decreased from 0.32 (Mar 24) to -3.06, marking a decrease of 3.38.
• For PBDIT Margin (%), as of Mar 25, the value is -3.76. This value is below the healthy minimum of 10. It has decreased from 5.71 (Mar 24) to -3.76, marking a decrease of 9.47.
• For PBIT Margin (%), as of Mar 25, the value is -7.55. This value is below the healthy minimum of 10. It has decreased from 3.34 (Mar 24) to -7.55, marking a decrease of 10.89.
• For PBT Margin (%), as of Mar 25, the value is -11.04. This value is below the healthy minimum of 10. It has decreased from 0.53 (Mar 24) to -11.04, marking a decrease of 11.57.
• For Net Profit Margin (%), as of Mar 25, the value is -11.04. This value is below the healthy minimum of 5. It has decreased from 0.53 (Mar 24) to -11.04, marking a decrease of 11.57.
• For Return on Networth / Equity (%), as of Mar 25, the value is -88.85. This value is below the healthy minimum of 15. It has decreased from 5.41 (Mar 24) to -88.85, marking a decrease of 94.26.
• For Return on Capital Employeed (%), as of Mar 25, the value is -41.34. This value is below the healthy minimum of 10. It has decreased from 21.01 (Mar 24) to -41.34, marking a decrease of 62.35.
• For Return On Assets (%), as of Mar 25, the value is -12.41. This value is below the healthy minimum of 5. It has decreased from 1.29 (Mar 24) to -12.41, marking a decrease of 13.70.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.12. This value is below the healthy minimum of 0.2. It has increased from 0.03 (Mar 24) to 0.12, marking an increase of 0.09.
• For Total Debt / Equity (X), as of Mar 25, the value is 2.84. This value exceeds the healthy maximum of 1. It has increased from 1.29 (Mar 24) to 2.84, marking an increase of 1.55.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.14. It has decreased from 2.12 (Mar 24) to 1.14, marking a decrease of 0.98.
• For Current Ratio (X), as of Mar 25, the value is 0.97. This value is below the healthy minimum of 1.5. It has decreased from 1.19 (Mar 24) to 0.97, marking a decrease of 0.22.
• For Quick Ratio (X), as of Mar 25, the value is 0.57. This value is below the healthy minimum of 1. It has decreased from 0.77 (Mar 24) to 0.57, marking a decrease of 0.20.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.77. This value is below the healthy minimum of 4. It has decreased from 2.60 (Mar 24) to 1.77, marking a decrease of 0.83.
• For Interest Coverage Ratio (X), as of Mar 25, the value is -1.08. This value is below the healthy minimum of 3. It has decreased from 2.03 (Mar 24) to -1.08, marking a decrease of 3.11.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -2.16. This value is below the healthy minimum of 3. It has decreased from 1.19 (Mar 24) to -2.16, marking a decrease of 3.35.
• For Enterprise Value (Cr.), as of Mar 25, the value is 105.87. It has decreased from 147.42 (Mar 24) to 105.87, marking a decrease of 41.55.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.65. This value is below the healthy minimum of 1. It has increased from 0.43 (Mar 24) to 0.65, marking an increase of 0.22.
• For EV / EBITDA (X), as of Mar 25, the value is -17.50. This value is below the healthy minimum of 5. It has decreased from 7.53 (Mar 24) to -17.50, marking a decrease of 25.03.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.34. This value is below the healthy minimum of 1. It has increased from 0.28 (Mar 24) to 0.34, marking an increase of 0.06.
• For Price / BV (X), as of Mar 25, the value is 2.77. This value is within the healthy range. It has decreased from 2.86 (Mar 24) to 2.77, marking a decrease of 0.09.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.34. This value is below the healthy minimum of 1. It has increased from 0.28 (Mar 24) to 0.34, marking an increase of 0.06.
• For EarningsYield, as of Mar 25, the value is -0.32. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 24) to -0.32, marking a decrease of 0.33.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness